|
|
Blood, 1 April 2005, Vol. 105, No. 7, pp. 2787-2792.
Prepublished online as a Blood First Edition Paper on December 14, 2004; DOI 10.1182/blood-2004-09-3388.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Ly49Q defines 2 pDC subsets in mice
Yumiko Kamogawa-Schifter,
Jun Ohkawa,
Sahori Namiki,
Naoko Arai,
Ken-ichi Arai, and
YongJun Liu
From the Department of Immunobiology, Ginkgo Biomedical Research Institute, Tokyo, Japan; Department of Molecular and Developmental Biology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan; and Department of Immunology, MD Anderson Cancer Center, University of Texas, Houston, TX.
Plasmacytoid dendritic cells (pDCs) play an important primary role for antiviral innate immunity by rapidly producing large amounts of type 1 interferon (IFN) upon viral infection. To study pDC biology, we generated a monoclonal antibody, termed 2E6, that recognizes pDCs. Molecular cloning of a cDNA encoding the 2E6 antigen revealed that it is a type II C-type lectin, Ly49Q, that consists of 247 amino acids with high homology to the natural killer (NK) receptor family Ly49, with an immunoreceptor tyrosine-based inhibitory motif in the cytoplasmic domain. Ly49Q is expressed on pDCs but not on NK cells or myeloid dendritic cells. B220+, CD11c+, CD11b– pDCs in bone marrow were divided into Ly49Q+ and Ly49Q– subsets. While both subsets produced IFN- upon cytosine-phosphate-guanosine (CpG) and herpes simplex virus stimulation, Ly49Q– pDCs responded poorly to influenza virus. In addition, Ly49Q– pDCs produced inflammatory cytokines such as interleukin 6 (IL-6), IL-12, and tumor necrosis factor (TNF-) upon stimulation at lower levels than those produced by Ly49Q+ pDCs. In contrast to bone marrow, Ly49Q+ pDCs were only found in peripheral blood, lymph nodes, and spleen. These results indicate that Ly49Q is a specific marker for peripheral pDCs and that expression of Ly49Q defines 2 subsets of pDCs in bone marrow.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Yoshizaki, A. Tazawa, E. Kasumi, S. Sasawatari, K. Itoh, T. Dohi, T. Sasazuki, K. Inaba, A. P. Makrigiannis, and N. Toyama-Sorimachi
Spatiotemporal regulation of intracellular trafficking of Toll-like receptor 9 by an inhibitory receptor, Ly49Q
Blood,
August 20, 2009;
114(8):
1518 - 1527.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Matsui, J. E. Connolly, M. Michnevitz, D. Chaussabel, C.-I Yu, C. Glaser, S. Tindle, M. Pypaert, H. Freitas, B. Piqueras, et al.
CD2 Distinguishes Two Subsets of Human Plasmacytoid Dendritic Cells with Distinct Phenotype and Functions
J. Immunol.,
June 1, 2009;
182(11):
6815 - 6823.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.-H. Tai, M.-L. Goulet, S. Belanger, N. Toyama-Sorimachi, N. Fodil-Cornu, S. M. Vidal, A. D. Troke, D. W. McVicar, and A. P. Makrigiannis
Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC
J. Exp. Med.,
December 22, 2008;
205(13):
3187 - 3199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Vremec, M. O'Keeffe, H. Hochrein, M. Fuchsberger, I. Caminschi, M. Lahoud, and K. Shortman
Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells
Blood,
February 1, 2007;
109(3):
1165 - 1173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Allman, M. Dalod, C. Asselin-Paturel, T. Delale, S. H. Robbins, G. Trinchieri, C. A. Biron, P. Kastner, and S. Chan
Ikaros is required for plasmacytoid dendritic cell differentiation
Blood,
December 15, 2006;
108(13):
4025 - 4034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Gays, J. G. Aust, D. M. Reid, J. Falconer, N. Toyama-Sorimachi, P. R. Taylor, and C. G. Brooks
Ly49B Is Expressed on Multiple Subpopulations of Myeloid Cells
J. Immunol.,
November 1, 2006;
177(9):
5840 - 5851.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Blasius, E. Giurisato, M. Cella, R. D. Schreiber, A. S. Shaw, and M. Colonna
Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation.
J. Immunol.,
September 1, 2006;
177(5):
3260 - 3265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Zhang, A. Raper, N. Sugita, R. Hingorani, M. Salio, M. J. Palmowski, V. Cerundolo, and P. R. Crocker
Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors
Blood,
May 1, 2006;
107(9):
3600 - 3608.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Fallarino, C. Orabona, C. Vacca, R. Bianchi, S. Gizzi, C. Asselin-Paturel, M. C. Fioretti, G. Trinchieri, U. Grohmann, and P. Puccetti
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells
Int. Immunol.,
November 1, 2005;
17(11):
1429 - 1438.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Huang, F. Rezzoug, H. Xu, P. M. Chilton, C. L. Schanie, I. Fugier-Vivier, and S. T. Ildstad
NK Cells Play a Critical Role in the Regulation of Class I-Deficient Hemopoietic Stem Cell Engraftment: Evidence for NK Tolerance Correlates with Receptor Editing
J. Immunol.,
September 15, 2005;
175(6):
3753 - 3761.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Omatsu, T. Iyoda, Y. Kimura, A. Maki, M. Ishimori, N. Toyama-Sorimachi, and K. Inaba
Development of Murine Plasmacytoid Dendritic Cells Defined by Increased Expression of an Inhibitory NK Receptor, Ly49Q
J. Immunol.,
June 1, 2005;
174(11):
6657 - 6662.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
